Southern African HIV Clinicians Society Conference 2018 programme subject to change 2 P a g e
|
|
- Wesley Fox
- 5 years ago
- Views:
Transcription
1 CONFERENCE PROGRAMME WEDNESDAY, 24 OCTOBER h00 18h00 Registration OFFICIAL MEETING COMMENCES 14h00 15h30 Session 1A Adolescent cases - Teen pregnancy and breast feeding - Previously on PrEP, now pregnant. What to do? (Tshidi Sebitloane) - Teen adherence (Juliet Houghton) Session 1B Adult cases (Michelle Venter, tba) - Adherence - Mental health - STIs - Opportunistic Infections - TB - Drug Interactions Panel discussion (Gary Maartens, Yunus Moosa, Francesca Conradie) Jeremy Nel 15h30 16h00 Refreshments, exhibition and posters 16h00 17h30 Session 2: Open Session Debate: Undetectable = Untransmittable - Yes (Annemarie Wensing) - No (Graeme Meintjes) Yunus Moosa 17h40 19h00 Session 3: Opening Plenary Official conference opening Mechanism of resistance (Douglas Richman) HIV drug resistance: are we about to win the war? (John Mellors) Annemarie Wensing 19h00 21h00 Opening Cocktail Function Session 1C Skills building - Nurse cases - Cases primary healthcare, rural doctors (Ndiviwe Mphothulo, Jenny Nash) - Cases nurses (Talitha Crowley, Gloria Mthombeni) - Panel discussion: Integration; Restarting (Ndiviwe Mphothulo, Talitha Crowley, Gloria Mthombeni, Jenny Nash Gloria Maimela Southern African HIV Clinicians Society Conference 2018 programme subject to change 2 P a g e
2 THURSDAY, 25 OCTOBER h30 08h15 Session 4A Stock outs and medicine availability - Stop Stockouts Project - Essential medicines to add to the formulary - TB 08h20 10h15 10h15 10h30 10h30 12h00 12h00 13h30 Session 5: Plenary Session How are we doing with HIV self-screening? (Francois Venter) - How are we doing with Universal test and treat? - How are we doing with viral suppression? (Sergio Carmona) Refreshments, exhibition and posters Session 6A PrEP consult - How to administer PrEP: a typical clinical consultation (Muhangwi Mulaudzi) - How to bill PrEP coding (Siraaj Adams) - The experience of a treating physician (Eric Hefer) Moeketsi Mathe Lunch, exhibition and posters Session 6B Skills building session Infant testing - Swallowing tablets (Leon Levin) - Optimising formulations (Carol Ruffell) - The latest on infant testing, and how to access - Switching in children (Helena Rabie) - Weight and age (Helena Rabie) James Nuttall Session 4B Ethics and research - The informed consent process (Lucy Allais and Mary Carman) Session 6C Ethics and the Law - Whistle-blowing in the health-sector - Mandatory testing - Ethics on how health budgets are split (Marije Versteeg-Mojanaga) - Q&A Lucy Allais Satellite Session Southern African HIV Clinicians Society Conference 2018 programme subject to change 3 P a g e
3 GlaxoSmithKline session 13h30 15h00 15h00 15h30 15h30 17h00 Session 8A Cancer treatment models - Kaposi Sarcoma (Zainab Mohamed) - Lymphoma - Role of pap smears in the HIV world - Update on cancer treatment (Adam Nosworthy) Moosa Patel Refreshments, exhibition and posters Hall 5 Session 9A An update on - Integrase inhibitors (Francois Venter) - Protease Inhibitors (Sipho Dlamini) - NRTIs (Yunus Moosa) - NNRTIs (Michelle Moorhouse) - Drug-drug interaction (Gary Maartens) Session 8B Resistance - Viral resistance first-line and second-line (Graeme Meintjes) - At which detectable viral load should we switch? (Lucas Hermans) - Third-line treatment. Feedback on outcome of patients on national third-line regimen (Michelle Moorhouse) - Transmitted drug resistance: surveillance, implications, future (Cloete van Vuuren) Theresa Rossouw Session 9B What s coming / What s missing in paediatrics - Integrase inhibitors (James Nuttall) - Protease Inhibitors (Leon Levin) - Drug interactions (Mohendren Archary) Session 8C Prevention - Non-biomedical approaches (Sue Goldstein) - Condoms (Mags Beksinska) - Update on trials of vaccines and monoclonals in SA; how PrEP could augment these approaches (Fatima Laher) - Voluntary medical male circumcision (Limakatso Lebina) - Treatment as prevention (Francois Venter) Session 9C Modelling and scale-up - What are the numbers telling us - How the epidemic informs resource planning Cost effectiveness of TLD versus TEE Southern African HIV Clinicians Society Conference 2018 programme subject to change 4 P a g e
4 17h10 18h40 18h50 20h20 Karen Cohen Session 10A Session 10B Skills building session Skills building session Resistance Counselling - Third-line (Leon Levin) - How to deliver HIV risk - Paediatric third-line reduction counselling in 2018 (Moherndran Archary) (Janan Dietrich) - Stanford database - how to - Integrating HIV prevention with interpret resistance test other services (Natasha Davies) results (Robert Shafer) Pierre Brouard Cloete van Vuuren Session 11: Debate (Open Session) Hall 4 Implications of scarcer resources for 90:90:90 (Gloria Maimela) - Panel: Elliot Raizes, Annemarie Wensing, Yunus Moosa, Jean Nachega, Francois Venter FRIDAY, 26 OCTOBER h30 08h15 Southern African HIV Clinicians Society AGM 08h30 10h00 10h00 10h30 Session 12: Plenary Our current understanding of antibodies (Nono Mhkize) Why do we need cure (John Mellors) How do you measure cure (Monique Nijhuis) Management of patients with advanced HIV (Graeme Meintjes) Moeketsi Mathe Refreshments, exhibition and posters Session 10C Skills building session - Basic science (Carole Wallis, Gillian Hunt, Tendesayi Kufa-Chakezha) Gillian Hunt 10h30 12h00 Session 13A Session 13B Session 13C Southern African HIV Clinicians Society Conference 2018 programme subject to change 5 P a g e
5 12h00 13h30 Opportunistic infections - An approach to intracranial mass lesions in HIV patients - Pneumocystis pneumonia - Endemic mycoses in HIV patients (Jade Mogambery) - An approach to chronic diarrhoea (Sipho Dlamini) Colin Menezes Lunch, exhibition and posters HIV and TB in children and adults - Paediatric TB diagnosis and management (Ashendri Pillay) - TB in children and HIV-TB coinfection - TB in adults and HIV-TB coinfection (Ndiviwe Mphothulo) - TB and HIV co-infection including IRIS Key populations and mobile populations - Injecting drug users in the region (Andrew Scheibe) - Sex workers including satellite clinics; peer support (Naomi Hill) - Engaging in care (Naomi Hill) - Testing in taxi ranks (Thandeka Khosa) Satellite Session 14 GILEAD session 13h30 15h00 15h00 15h30 15h30 17h00 Session 15: Plenary Botswana Dolutegravir experience (Ava Avalos) Could good point-of-care testing revolutionise issues in the region? (Peter Manyike) Balancing politicians, ministries of health, communities and donors Refreshments, exhibition and posters Session 16A Session 16B Session 16C Skills building Clinical skills building (Henry Sunpath, Yunus Moosa) TB - Should the private sector be treating TB? Yes No Kogie Naidoo Update on PMTCT - Where are we with PMTCT, including epidemiology (Landon Myer) - Transmission of HIV in breastfeeding (Ameena Goga) - Pregnant women on ART programmatic issues (Coceka Mnyani) Southern African HIV Clinicians Society Conference 2018 programme subject to change 6 P a g e
6 17h10 18h40 Session 17A Hall 4 DTG in pregnancy and breastfeeding - Contraception, clinical issues, MPTs and new technologies (Helen Rees) Tshidi Sebitloane 19h00 22h30 Celebratory Dinner (RSVP only additional fee applies) SATURDAY, 27 OCTOBER h30 08h15 Session 18A Meet the Professor / Clinician How did I start my academic / research career? (Dave Spencer; Francois Venter; Francesca Conradie; Yunus Moosa; Gary Maartens) Moeketsi Mathe 08h30 10h00 Session 19: Plenary Vaccinations - Overview (Benjamin Kagina) - Influenza vaccines (Shabir Madhi) - HIV vaccines - SAHCS vaccination guidelines (Sipho Dlamini) Rudzani Muloiwa 10h00 10h30 Refreshments, exhibition and posters 10h30 12h00 Session 20A Session 20B Noncommunicable diseases - Inflammation (Dave Spencer) - Hypertension Session 18B Adolescent health c/o Wits RHI Ethics and technology - Electronic medical records (Sandile Mhlongo) Session 20C Sexually transmitted infections - Strategies to achieve STI control in South Africa (Remco Peters) Southern African HIV Clinicians Society Conference 2018 programme subject to change 7 P a g e
7 12h00 13h30 - Obesity (Denasha Reddy) - Mental health - Injection drug use, HIV and hepatitis (Moeketsi Mathe) Lunch, exhibition and posters - Digital database and the PoPI act (Siraaj Adams) - Ethico-legal framework for biobank research in SA (Safia Mahomed) Funeka Bango - Hepatitis C (Andrew Scheibe) - Update on vaginal microbiome and HIV (Jo-Ann Passmore) - In context of PrEP (Sinead Delany- Moretlwe) - Management of STIs in HIV+ population case-based (Ranmini Kuluratne) Helen Rees Satellite Session 21 Johnson & Johnson session 13h30 15h00 15h10 16h40 16h50 18h15 Session 22A Advanced HIV Management - Care of aging patients - Cryptococcal meningitis (Charlotte Sriruttan) - Palliative care (Dave Spencer) Dave Spencer Session 23A Skills building Guidelines: all new (Sipho Dlamini, James Nuttall, Natasha Davies, Michelle Moorhouse) Moeketsi Mathe Session 24: Closing Plenary Big challenges in public health Session 22B Treatment optimisation - (Polly Clayden, Francois Venter, Gary Maartens, Michelle Moorhouse, Graeme Meintjes, Landon Myer) Polly Clayden Session 23B Adherence - Adherence (Catherine Orrell) - Adherence clubs - Role of viral load testing in adherence Maria Sibanyoni Session 22C Best abstracts session Moeketsi Mathe Session 23C Quality Improvement c/o the Aurum Institute Southern African HIV Clinicians Society Conference 2018 programme subject to change 8 P a g e
8 18h15 18h20 Big challenges in TB preventative therapy Big challenges in introducing and scaling up new prevention technologies (Helen Rees) Gary Maartens Conference closing Moeketsi Mathe Southern African HIV Clinicians Society Conference 2018 programme subject to change 9 P a g e
Session 1B - Auditorium Adult cases - Adherence - Mental health - STIs - Opportunistic Infections - TB - Drug Interactions Panel discussion
CONFERENCE PROGRAMME WEDNESDAY, 24 OCTOBER 2018 08h00 18h00 Registration OFFICIAL MEETING COMMENCES 14h00 15h30 Session 1A Adolescent cases - Teen pregnancy and breast feeding - Previously on PrEP, now
More information15h30 16h00. 16h00 17h30. 17h40 19h Southern African HIV Clinicians Society Conference 2018 programme subject to change 2 P a g e
CONFERENCE PROGRAMME WEDNESDAY, 24 OCTOBER 2018 08h00 18h00 Registration OFFICIAL MEETING COMMENCES 14h00 15h30 Session 1A Adolescent cases - Teen pregnancy and breast feeding (Julia Turner) - Previously
More informationversus CD4. PoC - Messaging - Specificity and - Ethics sensitivity of HIV - Feedback from diagnostic tests demonstration projects
PRE-CONFERENCE WORKSHOPS WEDNESDAY, 24 OCTOBER 2018 10h00 14h00 Pre-Conference Workshop Pre-Conference Workshop Pre-Conference Workshop Pre-Conference Workshop ITREMA trial feedback PrEP for the private
More informationSession 1B. - Hall 4. 15h30 16h00 Refreshments, exhibition and posters - Hall 5 16h00 17h30 Session 2: Open Session. - Hall 4
CONFERENCE PROGRAMME WEDNESDAY, 24 OCTOBER 2018 08h00 18h00 Registration OFFICIAL MEETING COMMENCES 14h00 15h30 Session 1A Adolescent cases - Teen pregnancy and breast feeding (Julia Turner) - Previously
More informationSession 1B. - Hall 4. - Hall 4
CONFERENCE PROGRAMME WEDNESDAY, 24 OCTOBER 2018 08h00 18h00 Registration OFFICIAL MEETING COMMENCES 14h00 15h30 Session 1A Adolescent cases - Teen pregnancy and breast feeding (Julia Turner) - Previously
More informationSA HIV Clinicians Society Conference Excelling in Clinical Care : Programme
WEDNESDAY, 24 SEPTEMBER 2014 SA HIV Clinicians Society Conference 2014 - Excelling in Clinical Care : Programme 12h00-19h00 REGISTRATION 10h00-14h00 PRE-CONFERENCE WORKSHOP Metropolitan Health sponsored
More informationSA HIV Clinicians Society Conference Excelling in Clinical Care : Programme
WEDNESDAY, 24 SEPTEMBER 2014 SA HIV Clinicians Society Conference 2014 - Excelling in Clinical Care : Programme 12h00-19h00 REGISTRATION 10h00-14h00 PRE-CONFERENCE WORKSHOP Metropolitan Health sponsored
More informationSA HIV Clinicians Society Conference Excelling in Clinical Care : Programme
SA HIV Clinicians Society Conference 2014 - Excelling in Clinical Care : Programme WEDNESDAY, 24 SEPTEMBER 2014 08h00-19h00 10h00-13h55 12h30 13h55 REGISTRATION PRE-CONFERENCE WORKSHOP Metropolitan Health
More informationImmunisation in people living with HIV. Dr Bernadett Gosnell, Department of Infectious Diseases, UKZN
Immunisation in people living with HIV Dr Bernadett Gosnell, Department of Infectious Diseases, UKZN Calculating immunisation s return on investment In Gavi-supported countries, 2011 2020 48x (full income
More informationGoal of this chapter. 6.1 Introduction Good practices for linkage to care General care for people living with HIV 84
Clinical guidelines across THE CONTINuUM OF CARE: LINKING PEOPLE DIAGNOSEd WiTH hiv infection to hiv care and treatment 06 6.1 Introduction 84 6.2 Good practices for linkage to care 84 6.3 General care
More informationWorld Health Organization. A Sustainable Health Sector
World Health Organization A Sustainable Health Sector Response to HIV Global Health Sector Strategy for HIV/AIDS 2011-2015 (DRAFT OUTLINE FOR CONSULTATION) Version 2.1 15 July 2010 15 July 2010 1 GLOBAL
More informationCatherine Martin. Abstract #157. SA AIDS Conference. June 2017
Catherine Martin SA AIDS Conference Integrated sexual and reproductive health services as an entry point to HIV testing, prevention and care for adolescent girls and young women in Johannesburg, South
More informationTasP and PrEP- Wishful thinking in the developing world?
TasP and PrEP- Wishful thinking in the developing world? Professor Helen Rees Executive Director, WRHI, Wits Reproductive Health and HIV Institute & Ad Hominem Professor, Department of Ob/Gyn, University
More informationFuture trends of drug resistance and prospects of antiviral therapy. Doug Richman International Drug Resistance Workshop Johannesburg 24 October 2018
Future trends of drug resistance and prospects of antiviral therapy Doug Richman International Drug Resistance Workshop Johannesburg 24 October 2018 The principles of HIV drug resistance are well established
More informationSouth Africa s National HIV Programme. Dr Zuki Pinini HIV and AIDS and STIs Cluster NDOH. 23 October 2018
South Africa s National HIV Programme Dr Zuki Pinini HIV and AIDS and STIs Cluster NDOH 23 October 2018 Overview The HIV and AIDS sub-programme at NDOH is responsible for: policy formulation, coordination,
More informationPLANNING INTEGRATED HIV SERVICES AT THE HEALTH CENTRE
CHAPTER 2 PLANNING INTEGRATED HIV SERVICES AT THE HEALTH CENTRE 2.1 INTRODUCTION Achieving quality integrated HIV services at your health centre is dependant on good planning and management. This chapter
More informationPROVIDING EXCELLENT PRIMARY CARE FOR PATIENTS LIVING WITH HIV
PROVIDING EXCELLENT PRIMARY CARE FOR PATIENTS LIVING WITH HIV Madhuri Lad, DO, FACOI, AAHIVS Clinical Assistant Professor OSU Department of Internal Medicine OBJECTIVES Demographics Definitions Diagnosis
More information7 th FIDSSA CONFERENCE 2017 Programme as at 11 May 2017 PROVISIONAL ACADEMIC PROGRAMME
THURSDAY 9 NOVEMBER 15h00 17h00 Conference Registration FIDSSA Official Opening Ceremony 17h00 17h15 Welcome & Opening - Marc Mendelson (FIDSSA President) PLENARY SESSION 1: Emerging and Re-Emerging Infectious
More informationIFMSA Policy Statement Ending AIDS by 2030
IFMSA Policy Statement Ending AIDS by 2030 Proposed by IFMSA Team of Officials Puebla, Mexico, August 2016 Summary IFMSA currently acknowledges the HIV epidemic as a major threat, which needs to be tackled
More informationOverview of Safer Conception Services at Wits RHI
SA AIDS Satellite Session 13 June 2017 Presented by Diantha Pillay on behalf of Dr. Natasha Davies, Sheree Swartz, Nicolette Naidoo & Saiqa Mullick Overview of Safer Conception Services at Wits RHI Safer
More informationEfavirenz vs dolutegravir for 1st line ART: Is it time to change? The argument AGAINST. Graeme Meintjes University of Cape Town
Efavirenz vs dolutegravir for 1st line ART: Is it time to change? The argument AGAINST Graeme Meintjes University of Cape Town Benefits of dolutegravir Superior efficacy in SINGLE trial Side effect profile
More informationHow are we doing with Universal Test and Treat?
How are we doing with Universal Test and Treat? Francois Venter October 2018 Thanks DoH, WHO, PEPFAR, CHAI, UCT, Joep Lange Institute, Celicia Serenata, Steve Smith, David Allen Optimising ART Consortia
More informationACCELERATING HIV COMBINATION PREVENTION HIV COMBINATION PREVENTION INTERVENTIONS
ACCELERATING HIV COMBINATION PREVENTION HIV COMBINATION PREVENTION INTERVENTIONS Dr T Chidarikire HIV PREVENTION STRATEGIES 13 JUNE 2017 1 Purpose To share the Health Sector HIV Prevention Strategy with
More informationITREMA is a collaborative project between several universities in The Netherlands and South Africa and Ndlovu Care Group.
ITREMA is a collaborative project between several universities in The Netherlands and South Africa and Ndlovu Care Group. Objective: To do research into the best way to use viral load testing to ensure
More informationManagement of HIV Infected Children and Adolescents: Public Sector Approach in Kenya
Management of HIV Infected Children and Adolescents: Public Sector Approach in Kenya KPA 2018 24-04-2018 Dr. Margaret Wainaina- Wafula Outline Introduction Evaluation of a child living with HIV. Standard
More informationImpact of South Africa s PMTCT Programs on Perinatal HIV Transmission: Results of the 1st Year Implementing 2010 WHO Recommended Guidelines
Impact of South Africa s PMTCT Programs on Perinatal HIV Transmission: Results of the 1st Year Implementing 2010 WHO Recommended Guidelines Thu-Ha Dinh, MD., MS., US CDC/GAP Ameena Goga, MD., MS., MRC/HSRU,
More informationUpdates on Revised Antiretroviral Treatment Guidelines Overview 27 March 2013
Updates on Revised Antiretroviral Treatment Guidelines 2013 Overview 27 March 2013 Introduction of Fixed Dose combination (FDC) FDCs will be available in facilities on 1 April 2013 The FDC ARV that will
More informationColloque scientifique : L économie de la prévention Analysis of Cost-Effectiveness of HIV Prevention
Colloque scientifique : L économie de la prévention Analysis of Cost-Effectiveness of HIV Prevention Julia Walsh MD, MSc Professor School of Public Health University of California Berkeley Objectives Cost-effectiveness
More informationObjectives. Outline. Section 1: Interaction between HIV and pregnancy. Effects of HIV on Pregnancy. Section 2: Mother-to-Child-Transmission (MTCT)
Objectives Prevention of Mother-to-Child Transmission (PMTCT) Teen Club Community Partners Training Programme By the end of the session participants will be able to: 1. Identify factors affecting the transmission
More informationEACS HIV Summer School PRELIMINARY PROGRAMME
EACS HIV Summer School Thursday, August 30, 2018 Monday, September 3, 2018 Montpellier, France This 5-day residential course is designed for clinicians experienced in HIV management who want an update
More informationImpact of ART resistance in sub Saharan Africa
Impact of ART resistance in sub Saharan Africa Elliot Raizes, MD Division of Global HIV/TB US Centers for Disease Control and Prevention ITREMA Resistance Training Workshop 24 October, 2018 Center for
More informationProgram to control HIV/AIDS
90-90-90 Program to control HIV/AIDS Hamid Sharifi Associate Professor in Epidemiology [sharifihami@gmail.com] 1 Targets for ending the AIDS epidemic 2 New HIV infections in low- and middle-income countries,
More informationInvesting for Impact Prioritizing HIV Programs for GF Concept Notes. Lisa Nelson, WHO Iris Semini, UNAIDS
Investing for Impact Prioritizing HIV Programs for GF Concept Notes Lisa Nelson, WHO Iris Semini, UNAIDS Top 5 Lessons Learned 1 2 3 4 5 Prioritize within the allocation amount Separate above allocation
More informationMultiple choice questions: ANSWERS
Multiple choice questions: ANSWERS Chapter 1. Diagnosis and promotion of serostatus awareness in sub-saharan Africa 1. Antiretroviral therapy reduces HIV transmission from a HIV- positive person to a susceptible
More information2nd line failure, provincial evaluation process for 3rd line therapy, 3rd line treatment options James Nuttall
2nd line failure, provincial evaluation process for 3rd line therapy, 3rd line treatment options James Nuttall Paediatric Infectious Diseases Unit, Red Cross War Memorial Children s Hospital & University
More informationHIV EPIDEMIC UPDATE: FACTS & FIGURES 2012
HIV EPIDEMIC UPDATE: FACTS & FIGURES 2012 Number of Cases Note: In this surveillance report, HIV cases include persons reported with HIV infection (non-aids), advanced HIV (non-aids) and AIDS within a
More informationBiomedical Prevention Update Thomas C. Quinn, M.D.
Biomedical Prevention Update Thomas C. Quinn, M.D. Associate Director of International Research National Institute of Allergy and Infectious Diseases Director, Johns Hopkins Center for Global Health Global
More informationEvolving HIV Treatment Paradigms What we need to know
Evolving HIV Treatment Paradigms What we need to know Benjamin Young International Association of Providers of AIDS Care Washington, DC, USA Evolving HIV Treatment Paradigms When/who to treat Better medicines
More informationPrioritized research questions for adolescent HIV testing, treatment and service delivery
Prioritized research questions for adolescent HIV testing, treatment and service delivery The World Health Organization (WHO) and the Collaborative Initiative for Paediatric HIV Education and Research
More informationGLOBAL AIDS MONITORING REPORT
KINGDOM OF SAUDI ARABIA MINISTRY OF HEALTH GLOBAL AIDS MONITORING REPORT COUNTRY PROGRESS REPORT 2017 KINGDOM OF SAUDI ARABIA Submission date: March 29, 2018 1 Overview The Global AIDS Monitoring 2017
More informationDifferentiated Care Improving Engagement and Retention in HIV Care. Meg Doherty, MD PhD MPH World Health Organization
Differentiated Care Improving Engagement and Retention in HIV Care Meg Doherty, MD PhD MPH World Health Organization Why differentiated care and how can it facilitate epidemic control Effects on linkage,
More informationTHE ROLE OF THE SOUTH AFRICAN SOCIETY OF PHYSIOTHERAPY IN SUPPORT OF THE NATIONAL HIV & AIDS AND STI STRATEGIC PLAN FOR SOUTH AFRICA
THE ROLE OF THE SOUTH AFRICAN SOCIETY OF PHYSIOTHERAPY IN SUPPORT OF THE NATIONAL HIV & AIDS AND STI STRATEGIC PLAN FOR SOUTH AFRICA 2012-2016 South African Society of Physiotherapy P.O. Box 752378 Gardenview
More informationCan we make first line ART better?
Can we make first line ART better? Dr Angela Hartwig 8 th SA AIDS Conference, Durban Skills Building Session 15 June 2017 With thanks to Francois Venter and the people who gave him slides Characteristics
More informationObjectives. HIV in the Trenches HIV Update for the Primary Care Provider, An Overview The HIV Continuum of Care.
1:30 2:30pm HIV Update SPEAKER Gordon Dickinson, MD Presenter Disclosure Information The following relationships exist related to this presentation: Gordon Dickinson, MD, has no financial relationships
More informationHIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS
POLICY BRIEF HIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS CONSOLIDATED GUIDELINES JULY 2014 Policy brief: Consolidated guidelines on HIV prevention, diagnosis, treatment and care for
More informationHIV Drug Resistance South Africa, How to address the increasing need? 14 Apr. 2016
HIV Drug Resistance South Africa, How to address the increasing need? 14 Apr. 2016 1 Thus the HIV DR needs to focus on prevention and then diagnostic capacity to 1 st provide VL monitoring for early &
More informationPEPFAR Priorities & HIV Drug Resistance: Where are we heading and what has us worried
PEPFAR Priorities & HIV Drug Resistance: Where are we heading and what has us worried Elliot Raizes, MD Division of Global HIV & TB CDC Center for Global Health May 3, 2016 Center for Global Health Division
More informationWHO WHO AIDS 2018 JOIN US AT
WHO AIDS 2018 JOIN US AT WHO at AIDS 2018 TEDROS GHEBREYESUS Director-General, WHO ZSUZSANNA JAKAB WHO Regional Director for Europe REN MINGHUI WHO Assistant Director-General for Communicable Diseases
More informationDiagnosing HIV/AIDS. Marissa Humphrey MSIV New York Medical College GE/NMF Scholar
Diagnosing HIV/AIDS Marissa Humphrey MSIV New York Medical College GE/NMF Scholar Introduction The World Health Organization estimates that 7 percent of all AIDS cases have occurred in Africa and the highest
More informationPAEDIATRIC HIV INFECTION. Dr Ashendri Pillay Paediatric Infectious Diseases Specialist
PAEDIATRIC HIV INFECTION Dr Ashendri Pillay Paediatric Infectious Diseases Specialist Paediatric HIV Infection Epidemiology Immuno-pathogenesis Antiretroviral therapy Transmission Diagnostics Clinical
More informationStrategies to achieve STI control in South Africa Prof Remco Peters
Strategies to achieve STI control in South Africa Prof Remco Peters 4 th South African HIV Clinicians Society Conference 27th of October 2018 The spectrum of STIs This presentation has been slightly amended
More informationINTERNAL QUESTIONS AND ANSWERS DRAFT
WHO CONSOLIDATED GUIDELINES ON THE USE OF ANTIRETROVIRAL DRUGS FOR TREATING AND PREVENTING HIV INFECTION Background: INTERNAL QUESTIONS AND ANSWERS DRAFT At the end of 2012, 9.7 million people were receiving
More informationDay Seven: Helping HIV Affected Children and Orphans
Note: This training material is continually being evaluated and updated to reflect current needs and best practices therefore it should be viewed as work in progress. Any person, organization, or institution
More informationUNGASS Declaration of Commitment on HIV/AIDS: Core Indicators revision
UNGASS Declaration of Commitment on HIV/AIDS: Core Indicators revision Updated version following MERG recommendations Context In light of country reports, regional workshops and comments received by a
More informationGuidelines on safer conception in fertile HIV infected individuals
Guidelines on safer conception in fertile HIV infected individuals couples Vivian Black Co-authors: L-G Bekker, H Rees, S Black, D Cooper, S Mall, C Mnyami, F Conradie, I Mahabeer, L Gilbert, S Schwartz,
More informationBUDGET AND RESOURCE ALLOCATION MATRIX
Strategic Direction/Function ILO Strengthened capacity of young people, youth-led organizations, key service providers and partners to develop, implement, monitor and evaluate HIV prevention programmes
More informationHIV Prevention in Clinical Care Settings
NORTHWEST AIDS EDUCATION AND TRAINING CENTER HIV Prevention in Clinical Care Settings Jeanne Marrazzo, MD, MPH Professor, Division of Allergy and Infectious Diseases University of Washington HIV Prevention
More informationDRAFT MTN Regional Meeting Westin Cape Town Hotel Cape Town, South Africa Saturday, September 22, 2018
Saturday, September 22, 2018 Registration (Old Harbour Lobby; 7:30 AM to ) 1 1 Sunday, September 23, 2018 Registration (Old Harbour Lobby; 7:30 AM to ) MTN EC (Open to EC members only) Ballroom West) MTN
More informationTowards universal access
Key messages Towards universal access Scaling up priority HIV/AIDS interventions in the health sector September 2009 Progress report Towards universal access provides a comprehensive global update on progress
More informationINTRODUCTION AND GUIDING PRINCIPLES
CHAPTER 1 INTRODUCTION AND GUIDING PRINCIPLES The Operations Manual is intended for use in countries with high HIV prevalence and provides operational guidance on delivering HIV services at health centres.
More informationTreat All : From Policy to Action - What will it take?
Strategy Finance Integration Cascade of services People centred Political Will Treat All : From Policy to Action - What will it take? Thursday, 9 June, 13.00 14.30 Conference Room 11, United Nations Questions
More informationEffective HIV & AIDS prevention strategies
Effective HIV & AIDS prevention strategies Prof Geoffrey Setswe Presentation at the PDM2008 Satellite Broadcast 5 July 2008 1 Structure of the presentation Evidence and types of evidence in HIV prevention
More informationPaediatric HIV Drug Resistance 26th-International-Workshop-on-HIV-Drug-Resistance-programme [2].tiff
Paediatric HIV Drug Resistance 26th-International-Workshop-on-HIV-Drug-Resistance-programme- 20171031[2].tiff Mo Archary King Edward VIII Hospital / UKZN Paediatric Infectious Diseases Unit Overview State
More informationArizona State Office of Rural Health Webinar Series
Arizona State Office of Rural Health Webinar Series Mute your phone &/or computer microphone Time is reserved at the end for Q&A Please fill out the post-webinar survey Webinar is being recorded Recording
More informationHIV Drug Resistance (HIVDR)
Technical Guidance Note for Round 10 Global Fund HIV Proposals HIV Drug Resistance (HIVDR) Rationale for including HIVDR prevention and assessment in the proposal June 2010 As access to ART services expands,
More informationIs dolutegravir a magic bullet for HIV/TB programmes?
Francois Venter Is dolutegravir a magic bullet for HIV/TB programmes? March 2018 Thanks Michelle Moorhouse, Graeme Meintjes, Gary Maartens, Celicia Serenata, Andy Hill, Polly Clayden, Gloria Maimela, Tom
More informationProgramme. Co-Chairs. Take the conversation further online follow AIDS #AIDS2016
EVIDENCE TOACTION This session will highlight the essential role that collaborative research plays in improving public sector policies and services for HIV treatment and prevention. Across southern Africa
More informationWHO HIV Drug Resistance Prevention and Assessment Strategy. Dr Richard Banda Technical Officer, HIV Drug Resistance WHO Inter-country Support Team
WHO HIV Drug Resistance Prevention and Assessment Strategy Dr Richard Banda Technical Officer, HIV Drug Resistance WHO Inter-country Support Team Eastern & Southern African Countries (ESA) 2 The HIV epidemic
More informationAnnex A: Impact, Outcome and Coverage Indicators (including Glossary of Terms)
IMPACT INDICATORS (INDICATORS PER GOAL) HIV/AIDS TUBERCULOSIS MALARIA Reduced HIV prevalence among sexually active population Reduced HIV prevalence in specific groups (sex workers, clients of sex workers,
More informationSession 1 Basic HIV Facts. Patient Navigation Intervention
Session 1 Basic HIV Facts Patient Navigation Intervention Session 1 HIV, the Viral Life Cycle & Understanding the Importance of HAART and Adherence https://www.aids.gov/hiv aids basics/just diagnosed with
More informationPage 1. Outline. Outline. Building specialized knowledge: HIV. Biological interactions. Social aspects of the epidemic. Programmatic actions
Harvard-Brazil Collaborative Public Health Field Course January 2014 Lecture # 8 Building specialized knowledge: HIV Aluisio Segurado Department of Infectious Diseases School of Medicine, University of
More informationGenotypic Resistance Testing in Routine Care in South Africa:
Genotypic Resistance Testing in Routine Care in South Africa: Is the Juice Worth the Squeeze? Mark Siedner Africa Health Research Institute Harvard Medical School Conflicts of Interest^* No financial conflicts
More informationSexual and Reproductive Health and HIV. Dr. Rita Kabra Training course in Sexual and Reproductive Health Research Geneva 2012
Sexual and Reproductive Health and HIV Dr. Rita Kabra Training course in Sexual and Reproductive Health Research Geneva 2012 Global estimates of HIV-(2009) People living with HIV 33.3 million [31.4 35.3
More informationModelling the impact of HIVDR : the cost of inaction
WHO Considering programmatic implications of rising levels of HIV drug resistance: finalizing the Global Action Plan Webinars 12 13 Dec 2016 Modelling the impact of HIVDR : the cost of inaction Andrew
More informationSA HIV Clinicians Society Adult ART guidelines
SA HIV Clinicians Society Adult ART guidelines In draft format Graeme Meintjes (on behalf of the guidelines committee) Selected topics When to start ART First-line Second-line Third-line Patients with
More informationART for prevention the task ahead
ART for prevention the task ahead Dr Teguest Guerma WHO/HQS WHO's role and vision Status of the epidemic Overview Progress and challenges in treatment and prevention scale up ART for prevention Questions
More informationTRANSITION TO NEW ANTIRETROVIRALS IN HIV PROGRAMMES
POLICY BRIEF HIV TREATMENT TRANSITION TO NEW ANTIRETROVIRALS IN HIV PROGRAMMES JULY 2017 WHO This policy brief provides advice on a phased approach to transitioning to new WHO-recommended HIV treatment
More informationETHICS IN HIV PREVENTION RESEARCH IN THE NEW ERA OF
ETHICS IN HIV PREVENTION RESEARCH IN THE NEW ERA OF PrEP MTN Regional Meeting Cape Town 20 September 2017 Dhevium Govender South African Medical Research Council HIV Prevention Research Unit Quality/Regulatory
More informationTHE POWER OF UNDETECTABLE. What you need to know about HIV treatment as prevention
THE POWER OF UNDETECTABLE What you need to know about HIV treatment as prevention CONTENTS 3 Treatment as prevention First, a few basics: What is an undetectable viral load? How do I know if I m undetectable?
More informationMODERN ART FOR AFRICA
MODERN ART FOR AFRICA March 2018 A guide for HIV treatment activists and communities in lowand middle-income countries ART today A pricing agreement was recently announced that will speed up access to
More informationVI.2 Elements for a Public Summary VI.2.1 Overview of Disease Epidemiology
VI.2 Elements for a Public Summary VI.2.1 Overview of Disease Epidemiology HIV stands for human immunodeficiency virus. If left untreated, HIV can lead to the disease AIDS (acquired immunodeficiency syndrome).
More informationPaediatric Infectious Diseases Unit, Red Cross War Memorial Children s Hospital & University of Cape Town
A Public Sector Antiretroviral Treatment Programme for Treatment-Experienced Children and Adolescents in the Western Cape Province of South Africa Using Darunavir/Ritonavir-, Raltegravir- and Etravirine-Containing
More informationAchieving the 3 rd 90 in PEPFAR-supported countries:
Center for Global Health Achieving the 3 rd 90 in PEPFAR-supported countries: What will it take? Is it enough? Elliot Raizes, MD Division of Global HIV and TB Centers for Disease Control and Prevention
More informationCan we make first line ART better?
Can we make first line ART better? Dr David Stead Treatment Optimization HIV Clinicians Society Workshop 25 November 2017 With thanks to Francois Venter and the people who gave him slides Characteristics
More informationOverview of Paediatric HIV Treatment and Prevention: From Then to Now. Peter Mugyenyi, Joint Clinical Research Centre Kampala, Uganda
Overview of Paediatric HIV Treatment and Prevention: From Then to Now Peter Mugyenyi, Joint Clinical Research Centre Kampala, Uganda Outline The plight of HIV infected children (1980s and 1990s) Trends
More informationElements of Reproductive Health
SEXUAL& REPRODUCTIVE HEALTH and HIV/AIDS INTEGRATION: Issues for consideration Dr. Chris Baryomunsi, MP Parliament of Uganda Elements of Reproductive Health Safe motherhood Family Planning Prevention and
More informationUpdate on Biomedical Prevention. Thomas C. Quinn, MD, MSc
Update on Biomedical Prevention Thomas C. Quinn, MD, MSc Associate Director of International Research National Institute of Allergy and Infectious Diseases Director, Johns Hopkins Center for Global Health
More informationTB and HIV co-infection including IRIS
TB and HIV co-infection including IRIS Richard Lessells SAHCS Conference 2018 Clinical scenario 1 36-year-old male Presents with cough, fever & weight loss HIV test positive (new diagnosis) Sputum Xpert
More informationReview of the Democratic Republic of the Congo (DRC) by the Committee on the Elimination of Discrimination Against Women (CEDAW)
Review of the Democratic Republic of the Congo (DRC) by the Committee on the Elimination of Discrimination Against Women (CEDAW) Submission: Elizabeth Glaser Pediatric AIDS Foundation June 2013 Introduction:
More informationTranslating Science to end HIV in Latin America and the Caribbean
Translating Science to end HIV in Latin America and the Caribbean Mexico City, Mexico, 17 th - 18 th and 21 st April www.iasociety.org IAS 2017 post-conference workshop, 17 April 2018 Challenges for PrEP
More informationHIV Treatment as Prevention (TasP)
HIV Treatment as Prevention (TasP) Last updated: April 3, 2019 Together, we can change the course of the HIV epidemic one woman at a time. #onewomanatatime #thewellproject What Is Treatment as Prevention?
More informationPRECONCEPTION COUNSELING
PRECONCEPTION COUNSELING A Counseling Guide for Healthcare Providers Preconception Care & Counseling 1 Introduction Pregnancy planning and preconception care are important in order to: 1. Ensure maternal
More informationStarting with the end in mind: Experience of transitioning to sustainable services (KZN)
Starting with the end in mind: Experience of transitioning to sustainable services (KZN) Hilton Humphries Adolescent Programme Director MA (Research Psychology), PhD candidate Position: Behavioural Scientist
More informationAdapting Treatment 2.0 in Viet Nam - Toward Universal and Sustainable Access -
Adapting Treatment 2.0 in Viet Nam - Toward Universal and Sustainable Access - Associate Professor, Bui Duc Duong, MD, Ph.D. Deputy Director General, Ministry of Health Socialist Republic of Viet Nam HIV
More informationHIV and AIDS Estimates
and AIDS Estimates Adults and children living with Adults aged 15 and over living with Women aged 15 and over living with Men aged 15 and over living with 220 000 [200 000-250 000] 210 000 [190 000-240
More informationEssential minimum package ALHIV service provision: Community level
Essential minimum package service provision: Community level Partner or Actor COMMUNITY HEALTH WORKERS (CHWs) Minimum components Key Activities Key Accountable Provide communitybased HCT Support treatment
More informationDiagnosis and Initial Management of HIV/AIDS: What the Primary Care Provider Should Know
Diagnosis and Initial Management of HIV/AIDS: What the Primary Care Provider Should Know Carolyn K. Burr, EdD, RN Co-Clinical Director Deputy Director François-Xavier Bagnoud Center December 17 th, 2013
More informationTB/HIV Monitoring & Advocacy Project Interview Tool
TB/HIV Monitoring & Advocacy Project Interview Tool This interview tool is based upon the Interim Policy on Collaborative TB/HIV Activities of the World Health Organization. 1 It is designed to help you
More informationLOGFRAME TEMPLATE FOR SWAZILAND. SIDA s Contributions
1 Outcome 7 countries have addressed barriers to efficient and effective linkages between HIV and SRHR policies and services as part of strengthening health systems to increase access to and use of a broad
More information